Publications
- Laura García-Vicente, Michael Borja, Vanessa Tran, Andrea Álvarez-Vázquez, Raquel Flores-Hernández, Alejandro Granados, Aaron McGeever, Yang-Joon Kim, Leah Dorman, Angela Detweiler, Honey Mekonen, Sheryl Paul, Angela O Pisco, Norma F Neff, Arantxa Tabernero. (2023) Single-nucleus RNA sequencing provides insights into the GL261-GSC syngeneic mouse model of glioblastoma. Biorxiv
- Talaverón, R., Matarredona, E. R., Herrera, A., Medina, J. M. & Tabernero, A. (2020) Connexin43 Region 266–283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation. International Journal of Molecular Sciences, 21(22), 8852.
- Pelaz, S. G., Jaraíz-Rodríguez, M., Álvarez-Vázquez, A., Talaverón, R., García-Vicente, L., Flores-Hernández, R., Gómez de Cedrón, M., Tabernero, M., Ramírez de Molina, A., Lillo, C., Medina, J. M. & Tabernero, A. (2020). Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283. EBioMedicine, 62:103134.
- Jaraíz-Rodríguez, M., Talaverón, R., García-Vicente, L., Pelaz, S. G., Domínguez-Prieto, M., Álvarez-Vázquez, A., Flores-Hernández, R., Sin, W. C., Bechberger, J., Medina, J. M., Naus, C. C., Tabernero, A. (2020) Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo. Neuro-Oncology, 22(4), 493-504.
- Aasen, T., Leithe, E., Graham, S. V., Kameritsch, P., Mayán, M. D., Mesnil, M., Pogoda, K., Tabernero, A. (2019). Connexins in cancer: bridging the gap to the clinic. Oncogene, 38(23), 4429-4451.
- Jaraíz-Rodríguez, M., González-Sánchez, A., García-Vicente, L., Medina, J. M., Tabernero, A. (2017). Biotinylated cell-penetrating peptides to study intracellular protein-protein interactions. Journal of Visualized Experiments, 130, e56457.
- Gangoso, E., Talaverón, R., Jaraíz-Rodríguez, M., Domínguez-Prieto, M., Ezan, P., Koulakoff, A., Medina, J. M., Giaume, C., Tabernero, A. (2017). A c-Src inhibitor peptide based on connexin43 exerts neuroprotective effects through the inhibition of glial hemichannel activity. Frontiers in Molecular Neuroscience, 10, 418.
- Jaraíz-Rodríguez, M., Tabernero, M. D., González-Tablas, M., Otero, A., Orfao, A., Medina, J. M., Tabernero, A. (2017). A short region of connexin43 reduces human glioma stem cell migration, invasion, and survival through Src, PTEN, and FAK. Stem Cell Reports, 9(2), 451-463.
- Domínguez-Prieto, M., Velasco, A., Vega, L., Tabernero, A., Medina, J. M. (2017). Aberrant co-localization of synaptic proteins promoted by Alzheimer’s disease amyloid-β peptides: protective effect of human serum albumin. Journal of Alzheimer’s Disease, 55(1), 171-182.
- González-Sánchez, A., Jaraíz-Rodríguez, M., Domínguez-Prieto, M., Herrero-González, S., Medina, J. M., Tabernero, A. (2016). Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes. Oncotarget, 7(31), 49819-49833.
- Tabernero, A., Gangoso, E., Jaraíz-Rodríguez, M., Medina, J. M. (2016). The role of connexin43–Src interaction in astrocytomas: a molecular puzzle. Neuroscience, 323, 183-194.
